Source:http://linkedlifedata.com/resource/pubmed/id/15738282
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2005-3-1
|
pubmed:abstractText |
Optimal management of nonsmall cell lung cancer (NSCLC) depends on tissue diagnosis and accurate staging. Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is minimally invasive and provides cytological confirmation of malignant mediastinal disease. The aim was to assess the accuracy of EUS-FNA in cases of enlarged mediastinal lymphadenopathy (LN) of unknown aetiology and in the staging of NSCLC. A total of 52 consecutive patients with stage I-IIIb NSCLC or enlarged mediastinal LN of unknown aetiology underwent EUS-FNA. Negative results were confirmed with a surgical procedure: mediastinoscopy, video-assisted thoracic surgery (VATS) or lobectomy with systematic mediastinal lymph node dissection. In total, 34 patients had EUS-FNA performed for diagnosis, whilst the remaining 18 had EUS-FNA for staging. The overall sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy (95% confidence interval) were 93% (77-99), 100% (78-100), 100% (87-100), 88% (63-99) and 95% (84-99), respectively. When EUS-FNA was used in patients with NSCLC, the sensitivity, specificity, PPV, NPV and accuracy were 92% (73-99), 100% (69-100), 100% (85-100), 83% (51-98) and 94% (80-99), respectively. For mediastinal LN of unknown aetiology, no malignant disease was missed. Endoscopic ultrasound-guided fine-needle aspiration is an accurate tool for assessing mediastinal lymph node involvement in nonsmall cell lung cancer and in the diagnosis of unexplained mediastinal lymphadenopathy. Endoscopic ultrasound-guided fine-needle aspiration is a minimally invasive procedure that can be used as an adjunct or alternative to mediastinoscopy.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0903-1936
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
410-5
|
pubmed:dateRevised |
2005-10-18
|
pubmed:meshHeading |
pubmed-meshheading:15738282-Aged,
pubmed-meshheading:15738282-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:15738282-Endosonography,
pubmed-meshheading:15738282-Female,
pubmed-meshheading:15738282-Humans,
pubmed-meshheading:15738282-Lung Neoplasms,
pubmed-meshheading:15738282-Lymph Nodes,
pubmed-meshheading:15738282-Lymphatic Metastasis,
pubmed-meshheading:15738282-Male,
pubmed-meshheading:15738282-Mediastinum,
pubmed-meshheading:15738282-Neoplasm Staging,
pubmed-meshheading:15738282-Prospective Studies,
pubmed-meshheading:15738282-Sensitivity and Specificity,
pubmed-meshheading:15738282-Sentinel Lymph Node Biopsy
|
pubmed:year |
2005
|
pubmed:articleTitle |
The accuracy of EUS-FNA in assessing mediastinal lymphadenopathy and staging patients with NSCLC.
|
pubmed:affiliation |
Dept of Gastroenterology, St Vincent's Hospital Melbourne, Fitzroy, Victoria 3065, Australia. caddygr@svhm.org.au
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Validation Studies
|